solitomab inn development code artificial bispecific monoclonal antibody investigated anticancer drug fusion protein consisting two singlechain variable fragments scfvs different antibodies single peptide chain kilodaltons one scfvs binds cells via receptor epcam tumor antigen gastrointestinal lung like bispecific antibodies unlike ordinary monoclonal antibodies solitumab forms link cells target tumor cell antigen causes cells exert cytotoxic activity tumor cells producing proteins like perforin granzymes independently presence mhc costimulatory molecules proteins enter tumor cells initiate cells action mimics physiological processes observed cell attacks tumor monoclonal article stub help wikipedia expanding ithttpsenwikipediaorgwikisolitomab